Rare diseases
Investigational molecules
Locations
Long-Term Safety Study of Everolimus for Patients with Tuberous Sclerosis Complex and Refractory Seizures
PolandStudy on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia
PolandStudy of Cemiplimab Alone and with RP1 for Patients with Advanced Skin Squamous Cell Carcinoma
PolandStudy Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
PolandStudy on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients
PolandStudy of RO7247669 at Different Doses for People with Previously Untreated Advanced Melanoma that Cannot be Removed by Surgery or Has Spread
PolandStudy Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer
PolandStudy on Tralokinumab for Moderate-to-Severe Atopic Hand Eczema in Patients Needing Systemic Therapy
PolandStudy on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study
PolandStudy of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors
PolandStudy on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
PolandStudy on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
